Great resource for reporters and policymakers discussing the overdose crisis and addiction – Leo Beletsky
Source from Changing the Narrative News
In midst of overdose crisis, Canada doesn’t need to wait to decriminalize drugs: expert
VANCOUVER — A Vancouver drug policy expert says Canada is ready for decriminalization, countering comments made by federal Health Minister Patty Hajdu during a visit to the Downtown Eastside last week.
“Criminalization of people who are addicted and mentally ill and street-engaged, there is not an upside to that,” said Donald MacPherson, the executive director of the Canadian Drug Policy Coalition and an adjunct professor at Simon Fraser University.
“It does nothing but harm people.”
While touring an overdose prevention site in Vancouver’s Downtown Eastside Thursday, Hajdu said Canada isn’t ready to for decriminalization, a step some other countries have taken.
That’s because there aren’t yet enough services in place to help people fight their addictions, and service levels vary from province to province, Hajdu said.
To MacPherson, the arguments against decriminializing possession for personal use sound familiar: nearly 20 years ago, when advocates were fighting to set up Vancouver’s first supervised injection site, the same objections were raised. He called Hajdu’s comments “political deflection.”
“Obviously, we would like to have more safe supply, more drug treatment services, more housing,” MacPherson told CTV News.
“That all needs to happen, but you can do it all – it’s not either/or.”
Insite was opened in 2003; extensive research proved the facility reduces overdoses deaths.
Vancouver has been in the grip of a deadly overdose crisis since 2016, when the black market drug supply began to be contaminated with the powerful synthetic opioid fentanyl. Since 2016, the opioid overdose crisis has killed nearly 14,000 Canadians, according to Statistics Canada.
With the blessing of the B.C. government and provincial health authority, advocates and organizations began open overdose prevention sites throughout the Downtown Eastside in 2016.
The model, where people come to use drugs and front-line workers can treat overdoses with the overdose reversal drug naloxone, has now been adopted in other cities across Canada.
In response to the crisis, Vancouver service agencies have also been expanding a model called safe supply, where drug users are prescribed prescription opioids so they aren’t using deadly contaminated street drugs.
This week, Dr. Mark Tyndall, an addictions expert and UBC professor, unveiled a vending machine that dispenses prescription drugs to regular opioid users with a history of overdose and fentanyl detected in their systems.
MacPherson said there’s no question there needs to be more of everything: more treatment services, more safe supply, more social supports and access to housing. And it’s provincial governments that need to step up on many of those files, because healthcare is a provincial responsibility, MacPherson added.
Where would decriminalization fit into the picture?
“You could decriminalize possession for personal use tomorrow, and you wouldn’t see much difference, except that you would remove the number one stigmatizing thing about people who use drugs: they’re criminals,” MacPherson said.
“You would be sending a strong message to healthcare providers, the police, the wider community, that if you are addicted to substances, we’re not going to treat you like a criminal and we want you to get better, we want you to get well and we want to help you.”
While B.C.’s overdose death rate has been falling, MacPherson warned the number of overdoses remain high.
“That tells me that the drug market is a still major toxic situation,” MacPherson said.
With files from The Canadian Press and CTV News Vancouver’s Alissa Thibault.
Story from CTV News Vancouver
Stephanie Lake and Michael Milloy: Now that cannabis is legal, let’s use it to tackle the opioid crisis
The legalization of cannabis for adult use in Canada is one of the biggest national public policy shifts that many of us will witness.
This historic change in drug policy was proposed by the Canadian government as a way to promote public health, as the country grapples with some of the highest cannabis consumption rates in the developed world, including among adolescents.
Meanwhile, Canada is struggling to contain an entirely different substance-related problem: The opioid overdose epidemic.
Fuelled by the contamination of the illicit drug supply with fentanyl and its analogues, the opioid epidemic is Canada’s gravest public health crisis since the emergence of HIV in the 1980s. Experts agree on the need for creative responses based on scientific evidence.
Increasingly, scientists from the fields of public health, medicine and economics are aiming to figure out if cannabis legalization could be part of the solution.
The possibilities are multiple — from the use of cannabis to treat chronic pain to the potential of cannabis to reduce opioid cravings.
We recently published a new study showing that highly marginalized patients on “opioid agonist therapy,” with the drugs methadone or suboxone, were more likely remain on their treatment six months later if they were using cannabis on a daily basis.
Almost one in five Canadians live with some form of chronic pain. In the 1990s, pharmaceutical companies began to develop slow-release formulations of opioids (e.g. OxyContin) and marketed them as safe and effective medications for the treatment of chronic non-cancer pain. Opioids are now known to carry a high risk of dependence and overdose and yet more than 20 million opioid prescriptions are still filled each year in Canada.
Cannabis, derived from the Cannabis sativa plant, contains several compounds, including tetrahydrocannabinol (THC, the primary psychoactive component of cannabis) and cannabidiol (CBD). Beyond the well-known psychoactive effects of cannabinoids, research shows that they also interact with systems in the body involved in the regulation of pain.
This discovery has led researchers to investigate the potential for cannabis to treat various pain conditions for which opioids are currently first- or second-line therapies.
Although high-quality clinical research involving cannabis has been stunted by its prohibited legal status and the quality of the experimental studies in question ranges from low to moderate, recent extensive reviews of experimental research on cannabinoids for chronic non-cancer pain generally agree that they offer modest relief of pain.
This begs the question: if cannabis becomes more available, do people switch from opioids to cannabis?
In a landmark 2014 study, a team of researchers analyzed data from across the U.S. over a 10-year period. They found that states with legalized medical cannabis saw 25 per cent fewer opioid-related deaths than states where medical cannabis remained illegal.
These findings broke ground for others in the field to find associations between U.S. medical cannabis laws and reduced state-level estimates of opioid prescriptions, misuse and dependence, as well as opioid-related hospitalizations and non-fatal overdoses.
Opioid overdose trends have also changed in the aftermath of recreational cannabis legalization in some U.S. states. For example, a recent study found that opioid-related deaths in Colorado were reduced (albeit modestly) relative to two comparison states in the short term following recreational cannabis legalization.
Although it’s tempting to conclude that increasing access to cannabis is an effective intervention against the opioid crisis, there are several reasons to be cautious when interpreting these study findings.
First, not all cannabis laws are created equal. For example, Colorado and Washington followed a commercialized approach to cannabis legalization with fewer restrictions around things like marketing and product sales compared to Canada’s public health framework. These regulations are likely to impact the ways in which people access and use cannabis products, which could create different shifts in other substance use trends.
Indeed, a study led by leading drug policy economists in the U.S. found that the passage of a medical cannabis law on its own was not associated with changes in opioid-related outcomes. Only after the authors accounted for access to cannabis through legal provisions for retail dispensaries did they find a 25-per-cent reduction in opioid-related deaths.
Second — and this is the subject of ongoing discussion among substance-use researchers — these population-level studies are limited by their inability to observe individual-level changes in cannabinoid and opioid use.
As a result, it’s impossible to conclude whether it was actually the change in law that created these shifts in opioid outcomes. To better understand this, we need to take a closer look at different sub-populations of opioid users.
Findings from surveys with medical cannabis users across North America demonstrate a clear preference for cannabis over opioids.
However, two recent high-impact studies challenge our understanding of this complex topic. A four-year study of Australians on opioid therapy for chronic pain did not find significant reductions in use of prescribed opioids or severity of pain among cannabis users.
More research is needed.
But what about the relationship between cannabis and opioids among some of those most affected by the opioid crisis — people with long-term experience using illicit opioids?
Untreated pain and substance use have a high degree of overlap. Pain was reported by almost half of people who inject drugs surveyed in a recent San Francisco study. Research from our colleagues in Vancouver found that under-treatment of pain in this population is common and results in self-management of pain using heroin or diverted prescription opioids, which is becoming increasingly more dangerous.
There is growing evidence for the use of cannabis in treating opioid addiction. CBD, the non-psychoactive component of cannabis, is known to interact with several receptors involved in regulating fear and anxiety-related behaviours. It shows potential for the treatment of several anxiety disorders.
Research is also investigating CBD’s role in modulating cravings and relapses — behaviours linked to anxiety — among individuals with opioid addiction. Recent preliminary studies suggest that CBD reduces opioid cravings. Our own research suggests that patients are more likely to stay in opioid agonist therapy during periods of intensive cannabis use.
The opioid overdose crisis is so dire in some regions that community harm reduction groups, like the High Hopes Foundation in Vancouver’s Downtown Eastside, are starting cannabis-based substitution programs that provide free access to cannabis products for drug users.
Canada is the first G-20 country to introduce a legal framework regulating the use of cannabis by adults. Legalizing cannabis will break down historic barriers to understanding its clinical and public health impacts. Canada should harness this opportunity to understand if, and how, cannabis legalization could fit into a multi-faceted opioid prevention and response strategy.
Stephanie Lake is a PhD student in population and public health at the University of B.C.; Michael Milloy is a research scientist at the B.C. Centre on Substance Use and an assistant professor of medicine at UBC. A longer version of this article was originally published on The Conversation, an independent and nonprofit source of news, analysis and commentary from academic experts.
Mark Haden – Is an Expert in Psychedelic Drug Research
- Counselling for parents with children with substance misuse issues or special needs.
- Critical incident debriefing.
- Training events for professionals (e.g. Harm Reduction, How to Provide Drug Education / Prevention in Schools, A Public Health Approach to Illegal Drugs, Understanding Dependency, Drugs and the Body)
- Public Education on dependency and illegal drugs
- Drug policy consultations
Click Here to go to – Mark Haden’s Web site
Measuring The Addiction Epidemic in Real-Time
By the time you finish reading this paragraph, over $80,000 has been poured into the war on drugs, over $95,000 has been spent on treating substance abuse, more than 400 new opiate prescriptions have been written and $190,000 has been spent buying illegal drugs. The United States is in middle of an epidemic. The following includes real-time counters to put into perspective the cost of substance abuse.
Measuring Addiction in Real Time – Click Here
Harm Reduction Guide
This website does not provide medical advice. The information, including but not limited to, text, graphics, images, and other material contained on this website are for informational purposes only. The purpose of this guide is to promote harm reduction and awareness of harm reduction methods. Detox Local does not condone, support, or promote the use of drugs or alcohol. This guide is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek advice from a physician regarding medical conditions and substance use. The information in this guide is true and complete to the best of our knowledge. All recommendations are made without guarantee of safety or the prevention of harm caused by drugs or alcohol. The author and Detox Local disclaim any liability in connection with the use of this information.
QUICK FACTS ABOUT #HARMREDUCTION
Reduction of risky behavior among those who participate in needle exchange program
Of AIDS cases among women are directly linked to IV drug use
Of needle exchange programs provide a large range of public health services
Harm reduction is a set of practical strategies and ideas aimed at reducing negative consequences associated with drug use. Obviously, complete abstinence is the most effective way to reduce drug-caused harm. The next best way is harm reduction. The best thing to compare it to is practicing safe sex – no sex prevents all harm, but safe sex significantly reduces STDs and unplanned pregnancy. Harm reduction works the same way. Many people are not willing or are not ready to stop using drugs. The safer they are while using drugs, the less disease, infection, and deaths will occur.
Harm reduction can be applied to every substance. There is always a safer way to use substances, whether they be alcohol, opioids, prescription drugs, crack, meth, or ecstasy. The most commonly known harm reduction is opioid and intravenous drug use harm reduction. This is because needle exchanges are becoming much more popular around the world including the United States. This is because needle exchanges are one of the most effective ways to prevent HIV/AIDS. According to the ACLU, more than a quarter of all Americans with HIV directly contracted the illness from intravenous drug use. Also, needle exchange programs have reduced HIV infections by one-third to two-fifths nationwide, so it is no surprise that their acceptance and popularity is increasing.
Harm Reduction Guide – Click Here